TRANSCODE THERAPEUTICS INC (RNAZ:NASDAQ)

$8.21 -0.34 (-3.9766%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 80

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed TRANSCODE THERAPEUTICS INC (RNAZ:NASDAQ) News Sources

TransCode Therapeutics Enters into Agreements for up to $20 Million Flexible Financing, Extending Company's Runway into Late 2027/Early 2028

07-04-2026

yahoo.com

CK Life Sciences Establishes Sequencio Therapeutics to Advance Therapeutic Cancer Vaccines Development

10-03-2026

yahoo.com

TransCode Secures Exclusive, Worldwide, Fully Paid-Up Royalty-Free License to Develop and Commercialize a Next-Generation Oncolytic Immunotherapy Platform in an All-Stock Transaction Underscoring the Company's Dedication to Improving the Lives of Cancer Patients

03-03-2026

yahoo.com

TransCode Therapeutics Announces Publication of Preclinical Testing of RIG-I Immunotherapeutic Candidate Supporting Further Development

23-02-2026

yahoo.com

TransCode Therapeutics and Quantum Leap Announce Submission of IND Amendment for Phase 2a Clinical Trial with TTX-MC138

05-02-2026

yahoo.com

TransCode Therapeutics Announces Publication of Preclinical Data Supporting Therapeutic Potential of TTX-MC138 in Glioblastoma

06-01-2026

yahoo.com

TransCode Therapeutics Expands Leadership with Appointment of Jack E. Stover to Board of Directors

22-12-2025

yahoo.com

TransCode Therapeutics and Quantum Leap Healthcare Collaborative Launch a Phase 2a dose-expansion trial with TTX-MC138, following positive readouts from TransCode's Phase 1 trial

11-12-2025

yahoo.com

TransCode Therapeutics Expands Executive Team with Appointment of Dr. Michel Janicot as Senior Development Officer

17-11-2025

yahoo.com

TransCode Therapeutics presents preliminary data from its completed Phase 1a study with TTX-MC138 in metastatic disease at ESMO

14-10-2025

yahoo.com

RNAZ stock
RNAZ stock price
RNAZ stock price today
RNAZ stock prediction
RNAZ earnings date
RNAZ news
RNAZ price
RNAZ share
RNAZ share price
RNAZ shares
RNAZ ceo
RNAZ premarket
$RNAZ
RNAZ ticker
RNAZ after hours
RNAZ stock
RNAZ stock price
RNAZ stock price today
RNAZ stock prediction
RNAZ earnings date
RNAZ news
RNAZ price
RNAZ share
RNAZ share price
RNAZ shares
RNAZ ceo
RNAZ premarket
$RNAZ
RNAZ ticker
RNAZ after hours

TRANSCODE THERAPEUTICS INC (RNAZ:NASDAQ) Sentiment Trend

View FAQ

TRANSCODE THERAPEUTICS INC (RNAZ:NASDAQ) FAQs

toggle

What is the current price of TRANSCODE THERAPEUTICS INC (RNAZ:NASDAQ)?

The current price of TRANSCODE THERAPEUTICS INC (RNAZ:NASDAQ) is $8.21.


toggle

TRANSCODE THERAPEUTICS INC (RNAZ:NASDAQ) absolute price change since previous trading day?

The absolute price change of TRANSCODE THERAPEUTICS INC (RNAZ:NASDAQ) since the previous trading day is $-0.34.


toggle

TRANSCODE THERAPEUTICS INC (RNAZ:NASDAQ) percentage price change since previous trading day?

The percentage price change of TRANSCODE THERAPEUTICS INC (RNAZ:NASDAQ) since the previous trading day is -3.9766%.


toggle

What is the most recent average sentiment score for TRANSCODE THERAPEUTICS INC (RNAZ:NASDAQ)?

The most recent average sentiment score for TRANSCODE THERAPEUTICS INC (RNAZ:NASDAQ) is 80 out of 100.


toggle

What is the most recent average sentiment for TRANSCODE THERAPEUTICS INC (RNAZ:NASDAQ)?

The most recent sentiment for TRANSCODE THERAPEUTICS INC (RNAZ:NASDAQ) is .


SEC-8K** Filing Available For TRANSCODE THERAPEUTICS INC (RNAZ:NASDAQ)

** material developments that could impact a company's financial condition or stock price.

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.